Literature DB >> 25633056

Catheter ablation of atrial fibrillation in patients with severely impaired left ventricular systolic function.

Ken Kato1, Koichiro Ejima2, Noritoshi Fukushima1,3, Makoto Ishizawa1,4, Osamu Wakisaka1,5, Ryuta Henmi1, Kentaro Yoshida1, Toshiaki Nuki1, Kotaro Arai1, Bun Yashiro1,6, Tetsuyuki Manaka1, Kyomi Ashihara1, Morio Shoda1, Nobuhisa Hagiwara1.   

Abstract

Little is known about the outcome of catheter ablation of atrial fibrillation (AF) in patients with heart failure (HF) and a severely reduced left ventricular ejection fraction (LVEF). We aimed to clarify the effectiveness of catheter ablation of AF in patients with a severely low LVEF. This retrospective study included 18 consecutive patients with HF and an LVEF of ≤ 35 % who underwent catheter ablation of AF. We investigated the clinical parameters, echocardiographic parameters and the incidence of hospitalizations for HF. During a median follow-up of 21 months (IQR, 13-40) after the final procedure (9 with repeat procedures), 11 patients (61 %) maintained sinus rhythm (SR) (6 with amiodarone). The LVEF and NYHA class significantly improved at 6 months after the CA in 12 patients (67 %) who were in SR or had recurrent paroxysmal AF (from 25.8 ± 6.3 to 37.0 ± 11.7 %, P = 0.02, and from 2.3 ± 0.5 to 1.5 ± 0.7, P < 0.01, respectively) but not in patients who experienced recurrent persistent AF. The patients with SR or recurrent paroxysmal AF had significantly fewer hospitalizations for HF than those with recurrent persistent AF after the AF ablation (log-rank test; P < 0.01). Catheter ablation of AF improved the clinical status in patients with an LVEF of ≤ 35 %. A repeat ablation procedure and amiodarone were often necessary to obtain a favorable outcome.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Heart failure; Pulmonary vein isolation; Systolic dysfunction

Mesh:

Year:  2015        PMID: 25633056     DOI: 10.1007/s00380-015-0635-7

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  27 in total

Review 1.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

2.  Impact of atrial remodeling on the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation.

Authors:  Koichiro Ejima; Ken Kato; Kotaro Arai; Keiko Fukushima; Noritoshi Fukushima; Tsuyoshi Suzuki; Kentaro Yoshida; Toshiaki Nuki; Shoko Uematsu; Hiromi Hoshi; Tetsuyuki Manaka; Kyomi Ashihara; Morio Shoda; Nobuhisa Hagiwara
Journal:  Circ J       Date:  2014-02-21       Impact factor: 2.993

3.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

Authors:  Oussama M Wazni; Nassir F Marrouche; David O Martin; Atul Verma; Mandeep Bhargava; Walid Saliba; Dianna Bash; Robert Schweikert; Johannes Brachmann; Jens Gunther; Klaus Gutleben; Ennio Pisano; Dominico Potenza; Raffaele Fanelli; Antonio Raviele; Sakis Themistoclakis; Antonio Rossillo; Aldo Bonso; Andrea Natale
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

4.  Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique.

Authors:  Feifan Ouyang; Matthias Antz; Sabine Ernst; Hitoshi Hachiya; Hercules Mavrakis; Florian T Deger; Anselm Schaumann; Julian Chun; Peter Falk; Detlef Hennig; Xingpeng Liu; Dietmar Bänsch; Karl-Heinz Kuck
Journal:  Circulation       Date:  2004-12-27       Impact factor: 29.690

5.  Catheter ablation for atrial fibrillation in congestive heart failure.

Authors:  Li-Fern Hsu; Pierre Jaïs; Prashanthan Sanders; Stéphane Garrigue; Mélèze Hocini; Fréderic Sacher; Yoshihide Takahashi; Martin Rotter; Jean-Luc Pasquié; Christophe Scavée; Pierre Bordachar; Jacques Clémenty; Michel Haïssaguerre
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

6.  Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation.

Authors:  Edward P Gerstenfeld; David J Callans; Sanjay Dixit; Andrea M Russo; Hemal Nayak; David Lin; Ward Pulliam; Sultan Siddique; Francis E Marchlinski
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

7.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

8.  Atrial tachycardia after circumferential pulmonary vein ablation of atrial fibrillation: mechanistic insights, results of catheter ablation, and risk factors for recurrence.

Authors:  Sanders Chae; Hakan Oral; Eric Good; Sujoya Dey; Alan Wimmer; Thomas Crawford; Darryl Wells; Jean-Francois Sarrazin; Nagib Chalfoun; Michael Kuhne; Jackie Fortino; Elizabeth Huether; Tammy Lemerand; Frank Pelosi; Frank Bogun; Fred Morady; Aman Chugh
Journal:  J Am Coll Cardiol       Date:  2007-10-15       Impact factor: 24.094

9.  A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure.

Authors:  David G Jones; Shouvik K Haldar; Wajid Hussain; Rakesh Sharma; Darrel P Francis; Shelley L Rahman-Haley; Theresa A McDonagh; S Richard Underwood; Vias Markides; Tom Wong
Journal:  J Am Coll Cardiol       Date:  2013-03-07       Impact factor: 24.094

10.  Long-term outcome and preprocedural predictors of atrial tachyarrhythmia recurrence following pulmonary vein antrum isolation-based catheter ablation in patients with non-paroxysmal atrial fibrillation.

Authors:  Koichiro Ejima; Kotaro Arai; Tsuyoshi Suzuki; Ken Kato; Kentaro Yoshida; Toshiaki Nuki; Futoshi Suzuki; Shoko Uematsu; Keiko Fukushima; Hiromi Hoshi; Tetsuyuki Manaka; Kyomi Ashihara; Morio Shoda; Nobuhisa Hagiwara
Journal:  J Cardiol       Date:  2013-12-25       Impact factor: 3.159

View more
  8 in total

1.  Noninvasive evaluation of reverse atrial remodeling after catheter ablation of atrial fibrillation by P wave dispersion.

Authors:  Yuhi Fujimoto; Kenji Yodogawa; Kenta Takahashi; Ippei Tsuboi; Hiroshi Hayashi; Shunsuke Uetake; Yu-Ki Iwasaki; Meiso Hayashi; Yasushi Miyauchi; Wataru Shimizu
Journal:  Heart Vessels       Date:  2017-06-19       Impact factor: 2.037

2.  Additional cryoapplications at the pulmonary vein antrum using a 28-mm second-generation cryoballoon: a pilot study of extra-pulmonary vein ablation.

Authors:  Shinsuke Miyazaki; Takatsugu Kajiyama; Tomonori Watanabe; Sadamitsu Ichijo; Yoshito Iesaka
Journal:  Heart Vessels       Date:  2018-02-20       Impact factor: 2.037

Review 3.  Invasive therapies for patients with concomitant heart failure and atrial fibrillation.

Authors:  Wei Wei; Michael Shehata; Xunzhang Wang; Fang Rao; Xianzhan Zhan; Huiming Guo; Xianhong Fang; Hongtao Liao; Jian Liu; Hai Deng; Yang Liu; Yumei Xue; Shulin Wu
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

4.  Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.

Authors:  Naoya Kataoka; Kunihiro Nishida; Koshi Kinoshita; Tamotsu Sakamoto; Yosuke Nakatani; Yasushi Tsujino; Koichi Mizumaki; Hiroshi Inoue; Koichiro Kinugawa
Journal:  Heart Vessels       Date:  2016-05-28       Impact factor: 2.037

5.  Improvement of left ventricular function after successful radiofrequency catheter ablation in persistent atrial fibrillation with preserved left ventricular ejection fraction: a comprehensive echocardiographic assessment using two-dimensional speckle tracking analysis.

Authors:  Tomoo Nagai; Junko Arakawa; Akira Hamabe; Hirotsugu Tabata
Journal:  J Echocardiogr       Date:  2018-10-01

6.  The impact of left atrial pressure on filtered P-wave duration in patients with atrial fibrillation.

Authors:  Hideyuki Kishima; Takanao Mine; Satoshi Takahashi; Kenki Ashida; Masaharu Ishihara; Tohru Masuyama
Journal:  Heart Vessels       Date:  2016-01-05       Impact factor: 2.037

Review 7.  Ablation for Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction.

Authors:  Jackson J Liang; David J Callans
Journal:  Card Fail Rev       Date:  2018-05

8.  Relationship between left ventricular diastolic dysfunction and very late recurrences after multiple procedures for atrial fibrillation ablation.

Authors:  Naoaki Onishi; Kazuaki Kaitani; Masashi Amano; Sari Imamura; Jiro Sakamoto; Yodo Tamaki; Soichiro Enomoto; Makoto Miyake; Toshihiro Tamura; Hirokazu Kondo; Chisato Izumi; Yoshihisa Nakagawa
Journal:  Heart Vessels       Date:  2017-08-01       Impact factor: 2.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.